Neuroleptic malignant syndrome: Possible induction by olanzapine in a case with relapsing catatonia

Abstract

Neuroleptic malignant syndrome is a serious medical condition with a significant mortality risk. Although it is less common with the atypical than the typical agents, it is described in association with clozapine and olanzapine. This report documents a case of possible induction of NMS in a patient with relapsing catatonia.